The b section event date was listed as "(b)(6) 2023".However, the actual event date could not be confirmed.Therefore, the event date was listed as the manufacture date, as the event could have only occurred after manufacture.The product investigation was completed.Device evaluation details: the device was returned to biosense webster for evaluation.A visual inspection, screening test of the returned device were performed following bwi procedures.Visual analysis revealed a cracked pebax in the tip area.The root cause of the damage could be related to improper handling; however, this cannot be conclusively determined.There are control inspection points to avoid these issues.A screening test was performed, and no temperature was displayed due to an open circuit in the tip area.However, the impedance was displayed properly.Based on the information currently available, two product issues were identified during the investigation of the sample received.It should be noted that product failure is multifactorial.A manufacturing record evaluation was performed for the finished device number 31047911l, and no internal action was found during the review.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.This product issue will be addressed through bwi's quality system.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Manufacturer's reference number: (b)(4).
|
A qdot micro¿ catheter was received by the biosense webster inc.(bwi) product analysis lab on 19-jul-2023, with no accompanying information and the device could not be associated with an existing complaint.In the absence of clarifying information, it cannot be determined why this device was returned to bwi.However, visual analysis conducted on 14-sep-2023 revealed a cracked pebax in the tip area.As such, this is now considered mdr reportable.The awareness date is 14-sep-2023.
|